BIOLASE INC Stock Price, News & Analysis

BIOLASE, Inc. (NASDAQ: BIOL), a leader in dental laser technology, announced its participation in the Benchmark Company Discovery One-on-One Virtual Investor Conference on December 2, 2021. The event will run from 8:00 a.m. to 4:30 p.m. Eastern Time and will include opportunities for individual meetings with investors. BIOLASE develops advanced laser systems used in dentistry, with over 41,200 systems sold globally. The conference is expected to attract more than 150 institutional investors and around 50 presenting companies.

BIOLASE, Inc. (NASDAQ: BIOL) is urging stockholders to vote in favor of a reverse stock split at the upcoming special meeting on November 19, 2021. The amendment aims to maintain the company's listing on The Nasdaq Capital Market and attract institutional investors. The board recommends approval to enhance liquidity, offer equity compensation, and ensure shares are available for future use. Leading proxy advisory firms, including Institutional Shareholder Services and Glass, Lewis & Co., have endorsed this proposal.

BIOLASE, Inc. (NASDAQ: BIOL) reported a 46% increase in net revenue for Q3 2021, totaling $9.5 million. A strong trend continued with 78% of U.S. laser sales from new customers. Laser system sales rose 64%, while consumables revenue grew 21%. Gross margin improved significantly to 51%, up 1,600 basis points. International revenue surged 101%. The company maintains a solid balance sheet with $33.4 million in cash. BIOLASE forecasts Q4 revenue to exceed pre-pandemic figures from 2019.

BIOLASE, Inc. (NASDAQ: BIOL) has launched the Epic Hygiene Academy, aiming to enhance dental hygiene education and patient care through laser technology. This program, available for BIOLASE diode laser users, focuses on empowering hygienists with advanced skills and resources, fostering superior preventive and therapeutic care. The academy will feature mentorship, interactive case reviews, and educational resources. Additionally, BIOLASE is donating an Epic Hygiene laser to Greenville Technical College, emphasizing its commitment to training future hygienists.

BIOLASE, Inc. (NASDAQ: BIOL) will release its third quarter 2021 financial and operating results on November 10, 2021, after U.S. financial markets close. A conference call and webcast will be held at 4:30 p.m. ET to discuss the results and corporate developments. Participants can join via dial-in numbers: (800) 367-2403 for U.S./Canada and (334) 777-6978 internationally, using Conference ID 3599686. The live webcast and an audio archive will be available on the BIOLASE Investor Events Page.

BIOLASE, Inc. (NASDAQ: BIOL) is urging stockholders to vote 'FOR' a proposed reverse stock split at a special meeting on November 19, 2021. This action aims to maintain compliance with Nasdaq's minimum bid price requirement of $1.00 per share, following a deficiency notification received earlier this year. A successful vote could help attract institutional investors, increase trading liquidity, and enable equity compensation for employees. The reverse stock split will not affect stockholders' percentage ownership.

BIOLASE, Inc. (NASDAQ: BIOL) announces an upcoming Q&A session for investors regarding a special meeting of stockholders on November 19, 2021, at 10:00 am PT. The company will utilize Say Technologies to facilitate investor questions prior to a webcast on October 25, 2021, at 1:00 pm PT. Investors holding BIOL stock as of October 1, 2021, can submit questions until October 19, 2021. More details can be found on BIOLASE's investor page.

BIOLASE, Inc. (NASDAQ: BIOL) and Healthy Smiles for Kids of Orange County are hosting an awareness reception on Sept. 24, from 5:00 p.m. - 7:00 p.m. at the BIOLASE Learning Center in Foothill Ranch, California. The event aims to enhance children's oral health in the community. Attendees can hear testimonials from families and providers utilizing BIOLASE's Waterlase dental lasers. The partnership also includes a donation of a Waterlase i-Plus laser to Healthy Smiles, which has served around 1 million children since its inception.

BIOLASE, Inc. (NASDAQ: BIOL) announced its schedule for investor conferences in September 2021. Key events include one-on-one meetings at the Colliers 2021 Institutional Conference on September 9 and a formal presentation at the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, with the presentation available on September 13 at 7:00 am ET. The company's leadership, including CEO John Beaver and VP of Finance Jennifer Bright, will participate in virtual meetings with institutional investors. More details can be found on BIOLASE's investor relations website.